Chimeric Therapeutics with Proactive at the ASX Small and Mid-Cap Conference

Chimeric Therapeutics CEO Jennifer Chow speaks with Proactive at the ASX Small and Mid-Cap Conference September 2022. Chimeric Therapeutics is a clinical stage cell therapy company. It believes that cellular therapies have the promise to cure cancer rather than just delay its progression. The company focuses on discovery, development and commercialisation of the most innovative cell therapies.
#ChimericTherapeutics #cancertherapy #asx #proactiveaustralia

You might like

© 2022 Stockmark.it The Latest StockMarket News and Interviews